Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 11th January 2019
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

New study may improve cancer treatment for dogs
The finding could lead to the development of a non-invasive prognostic test.
Finding could be used to assess how best to treat dogs with mast cell tumours

Scientists have successfully identified genetic changes in canine mast cell tumours that are linked to the spread of tumours.

The finding, made by vets at the Animal Health Trust and the University of Liverpool, could one day be used to determine how best to treat dogs with mast cell tumours, and may also promote the development of new treatments.

Scientists also say the finding could lead to the development of a non-invasive prognostic test which would tell vets if a cutaneous mast cell tumour is likely to spread, and therefore if chemotherapy is appropriate.

The availability of such a test would help ensure dogs receive the right cancer treatment and would reduce the number of dogs who receive treatment that is not beneficial. The findings have been published in the journal PLoS One.

“The findings of the research study is the result of many years work and are important because so many dogs are affected by cutaneous mast cell tumours,” explained study leader Dr Mike Starkey. “Cancer affects one in four dogs and research is the only way to fight cancer.

“I’m hugely grateful to everyone who has supported my team and this research to-date, and I believe this is a really exciting time as we can begin to see how our work can improve the outcome for dogs with cancer.”
 
He continued: “We spent a lot of time collecting a suitable group of mast cell tumour samples to allow us to study tumour spread, but we are very excited about the results and their potential relevance to dog health.”

The next step of the research is to further validate the accuracy of the results by conducting a larger retrospective study. To do this, the scientists will require the help of vets all over the country to collect the necessary tumour biopsies.

It is hoped the study will be completed within two years and work to develop the test could begin soon as 2021.

 

Become a member or log in to add this story to your CPD history

RCVS Knowledge appoints Veterinary Evidence editor-in-chief

News Story 1
 RCVS Knowledge has welcomed Professor Peter Cockcroft as editor-in-chief for Veterinary Evidence.

A world-renowned expert in evidence-based veterinary medicine, Prof Cockcroft will lead the strategic development and editorial quality of the open-access journal. He was previously in the role from 2017-2020.

Katie Mantell, CEO of RCVS Knowledge, said: "We are excited about the extensive knowledge of evidence-based veterinary medicine and clinical veterinary research that Peter brings, and we look forward to working with him over this next phase of the journal's development." 

Click here for more...
News Shorts
CVS Group hit by cyber attack

CVS Group, which owns more than 450 veterinary practices in the UK, has been hit by a cyber attack.

In a statement, the group said the incident involved unauthorised external access to a limited number of its IT systems. As soon as the attack was discovered, the group took its IT systems temporarily offline, causing 'considerable operational disruption'.

It has warned that the security steps taken and ongoing plans to move its operational systems and IT infrastructure to the Cloud are likely to have an ongoing impact over a number of weeks.

Due to the risk that personal information was accessed, CVS has informed the Information Commissioner's Office. The company is working with third party consultants to investigate the incident.